Past Events
2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Drug Regulation In Canada Webinar

This session reviews aspects of the Canadian Drug Regulatory System. It reviews the processes in place at Health Canada for seeking approval to use a drug in Canada.  This includes steps in the pre-market drug approval process, alternate pathways for approval (e.g. for orphan drugs), and the special access program. It also touches on post-market surveillance activies at Health Canada. In addition, this session highlights specific transformative efforts underway at Health Canada such as alignment of Health Technology Assessment activities related to pre-market drug submissions and consideration of the inclusion of real world data into premarket submissions.

Link to Webinar